ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Specialty Chemicals

Clariant in turmoil after joint venture talks with Sabic collapse

Setback occurs following CEO’s resignation; firm now plans to sell its masterbatch business instead of including it in the joint venture

by Marc S. Reisch
July 25, 2019 | APPEARED IN VOLUME 97, ISSUE 30

 

20190725lnp1-catalysts.jpg
Credit: Clariant
Catalysts will remain a core business for Clariant.

Just one day after Ernesto Occhiello unexpectedly resigned as CEO of Clariant for personal reasons, Clariant and Sabic say they are suspending discussions on the formation of a high-performance materials joint venture.

In a July 25 announcement, Switzerland-based Clariant chalked up the suspension to deteriorating market conditions. Sabic, a Saudi Arabia-based chemical giant, says it “looks forward to continuing these discussions” once conditions improve.

The discussions, if and when they resume, are likely to consider a very different venture.  Clariant now says that it will sell its high-value masterbatches portfolio, once destined to be part of the venture.

Clariant says that proceeds from selling the high-value masterbatches business—along with standard masterbatches and pigment businesses already marked for sale—will go to underwrite investments in new technology for core specialty businesses such as care chemicals and catalysts and to strengthen its balance sheet. Clariant adds that it will also return some of the proceeds to shareholders.

The end of the Sabic joint venture for now is just the latest setback for Clariant, which has been going through a turbulent period. In 2017, Clariant ended talks on a $20 billion merger with Huntsman Corp. following opposition from the activist investors White Tale Holdings and 40 North. Sabic bought the investors’ 25% stake in Clariant in January 2018 for $2.4 billion.

Sabic and Clariant first started talks to set up the materials joint venture in September 2018. The plan was to create a business with $3.2 billion in annual sales by combining Clariant’s polymer additives and high-value masterbatches business with Sabic’s Ultem and Noryl engineering polymer operations and its LNP compounded polymer unit.

Then in October, Occhiello joined Clariant as CEO. He appeared to be just the man for the job since he previously headed Sabic’s specialties business. Among his responsibilities was setting up the materials joint venture. With Occhiello now gone after just 10 months on the job, Clariant Chairman Hariolf Kottmann will take on CEO duties until the firm finds a successor.

Kottmann faces a deteriorating chemical market that is already cutting into Clariant’s results. The firm reported a net loss of $102 million in the first six months of 2019 versus a net gain of $213 million in the same period a year ago. “Despite the uncertainties of the current economic environment, the growth profile of our continuing portfolio remains unchanged,” Kottmann says.

X

Article:

This article has been sent to the following recipient:

Comments
Dr. Paul C. Li (July 31, 2019 10:47 PM)
Dear C&EN Ed.: Huntsman and Clariant ended the deal short of one mile, so was the Sabic and Clariant’s joint voyage sank in the middle of no return. It’s not techno-advances, it’s the timing of cultivation that administration and investors could no longer work together. The pride of technology is on one side and the prejudice of holding resource in control of money fund is on the other side who is to blame?
I read and studied Huntsman’s technical notes very carefully and felt convinced for me to inform my current and old friends to use Huntsman’s products. They have been progressively succeeded in their product formulations. On the other hand, the news release of Clariant’s products and applications through a third party poses no real impression for me to take actions to keep my old acquaintances happy.
Chemistry is not a sale and a buy measurable in money but in mine of unfulfilled objectives.
Submitted to your attention by a life long chemist pursuing better life through better chemistries strung together.

Leave A Comment

*Required to comment